US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
アメリカ
USOTC
Allergy Therapeutics Plc (PK) (AGYTF) 銘柄情報

Allergy Therapeutics Plc (PK) (AGYTF)

0.15

0.01

(7.14%)

終了 7月5日 5:00AM

Allergy Therapeutics Plc (PK) (AGYTF) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

0.15

( 7.14% )

買値

0.15

売値

0.14

出来高

7,142

0.15 日の範囲 0.15

0.085 52 週間の範囲 0.15

時価総額

前日終値

0.14

始値

0.15

時刻

最終取引時間

財務取引量

US$ 1,071

VWAP

0.15

平均取引量 (3 か月)

US$ 245,907

発行済株式数

6,332,529,550

配当利回り

PER

-6.53

1 株当たり利益 (EPS)

-0.01

歳入

57.29M

純利益

-48.18M

Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, ... Allergy Therapeutics plc, a commercial biotechnology company, focuses on the diagnosis and treatment of allergic disorders in Germany, Austria, United Kingdom, Netherlands, Switzerland, Italy, Spain, and internationally. The company sells injectable and sublingual allergen-specific immunotherapies, and offers treatment of pollen-related allergies, particularly to grasses, weeds, and trees, as well as diagnostics products. Its products include Pollinex Quattro, Oralvac, Venomil, Venom ATL Polistes Dominula, Synbiotics, and Acarovac Plus. It also develops Grass MATA MPL, a subcutaneous allergen-specific immunotherapy candidate that aims to address the cause of symptoms of allergic rhinoconjunctivitis due to grass pollen; and VLP Peanut, a short-course peanut allergy vaccine. Allergy Therapeutics plc was founded in 1998 and is headquartered in Worthing, the United Kingdom. 詳細を表示

セクター

Healthcare

業界

Pharmaceuticals

ウェブサイト

www.allergytherapeutics.com

本社

Worthing, United Kingdom

設立

1998

Allergy Therapeutics Plc (PK) is listed in the Healthcare sector of the その他OTC with ticker AGYTF. The last closing price for Allergy Therapeutics (PK) was US$0.14. Over the last year, Allergy Therapeutics (PK) shares have traded in a share price range of US$ 0.085 to US$ 0.15.

Allergy Therapeutics (PK) currently has 6,332,529,550 shares in issue. The market capitalisation of Allergy Therapeutics (PK) is US$949.88 million. Allergy Therapeutics (PK) has a price to earnings ratio (PE ratio) of -6.53.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0.01	7.14285714286	0.14	0.15	0.14	25000	0.14	CS
4	0.01	7.14285714286	0.14	0.15	0.14	25000	0.14	CS
12	0.04	36.3636363636	0.11	0.15	0.11	5167	0.13774194	CS
26	0.04	36.3636363636	0.11	0.15	0.11	3444	0.13774194	CS
52	0.065	76.4705882353	0.085	0.15	0.085	2929	0.11529872	CS
156	0.14	1400	0.01	0.15	0.01	2798	0.0920687	CS
260	-0.1	-40	0.25	0.539	0.01	5318	0.20707715	CS

AGYTF - Frequently Asked Questions (FAQ)

What is the current Allergy Therapeutics Plc (PK) share price?

The current share price of Allergy Therapeutics Plc (PK) is US$ 0.15

How many Allergy Therapeutics Plc (PK) shares are in issue?

Allergy Therapeutics Plc (PK) has 6,332,529,550 shares in issue

What is the market cap of Allergy Therapeutics Plc (PK)?

The market capitalisation of Allergy Therapeutics Plc (PK) is USD 949.88M

What is the 1 year trading range for Allergy Therapeutics Plc (PK) share price?

Allergy Therapeutics Plc (PK) has traded in the range of US$ 0.085 to US$ 0.15 during the past year

What is the PE ratio of Allergy Therapeutics Plc (PK)?

The price to earnings ratio of Allergy Therapeutics Plc (PK) is -6.53

What is the cash to sales ratio of Allergy Therapeutics Plc (PK)?

The cash to sales ratio of Allergy Therapeutics Plc (PK) is 6.96

What is the registered address of Allergy Therapeutics Plc (PK)?

The registered address for Allergy Therapeutics Plc (PK) is Dominion Way, Worthing, West Sussex, BN14 8SA

What is the Allergy Therapeutics Plc (PK) website address?

The website address for Allergy Therapeutics Plc (PK) is www.allergytherapeutics.com

Which industry sector does Allergy Therapeutics Plc (PK) operate in?

Allergy Therapeutics Plc (PK) operates in the Pharmaceuticals sector

GoodGuyBill

GoodGuyBill 8分前

$35 billion is far too low for a treatment that will treat all tumor-based cancers (and we are not even discussing DIRECT, the combo patent, etc).

santafe2

santafe2 12分前

And since we're applying more detail than most will care about, let me add that this is Jefferson and his committee presenting the draft of the declaration, not the signing. Thanks for your input here.

Johnnycombat10

Johnnycombat10 12分前

I'm not counting on shorts. I'm counting on progress with DBMM.

SonicProphet49

SonicProphet49 15分前

Cryptocurrency Recovery Services: Why Acting Fast Can Make a Difference

Recovering Lost or Stolen Cryptocurrency: The Importance of Time

The cryptocurrency market continues to grow, bringing new opportunities for investors, traders, and businesses worldwide. Unfortunate

Philbot

Philbot 19分前

Valid points. Won't it get delisted by not paying its annual listing dues or annual filing statements? It probably should have been auto-delisted by now.

GoodGuyBill

GoodGuyBill 24分前

Thanks. Wish I could return the complement.

https://investorshub.advfn.com/uimage/uploads/2026/7/4/rlzkdBadpost.jpg

m0n

Imagine having a product since 2009 LoL.
Cant even pay the bills and continue to have decades upon decadesof $2.2 million in deficits. LOL
No One is Fooled

m0n

How many shareholders have passed away? I m aware of one but feel there’s more.
I FU S website has ionic studies from 2009. LoL
30 YEARS IS FASTLY APPROACHING! LoL
Same o Same o, Keep the awareness on the possibilities LoL.
No One is Fooled

barnyarddog

barnyarddog 36分前

AI Overview - Avalanche Treasury Co. (ticker: AVAT) is a Nasdaq-listed operating company that provides public market investors with direct exposure to the Avalanche blockchain ecosystem.

Rather than merely stockpiling digital assets, AVAT actively allocates capital across the Avalanc

m0n

Past 6 months WIP $150 &$130k LoL
Can’t even pay the bills without door knocking for SSI $$$ in January 2026LoL
What a Joke!
No One is Fooled

TightCoil

TightCoil 46分前

Glen Bradford - Looks Like Trump Team Simply Maximizing Frannie IPO (OTCMKTS:FNMAS)
Seeking Alpha - 17 hours ago

TechBullion
Could Pepeto Be the Best Crypto Presale to Buy as
Fannie Mae Opens the Door to Crypto Mortgages?
5 hours ago

weenphan

weenphan 53分前

https://www.otcmarkets.com/stock/CVALF/profile

Kool Aid Man

Kool Aid Man 54分前

Measly $44k left in the gas tank

40 million shares left to issue x .0011

No one goes public if they intend to self finance operations. The whole point is to print and sell shares to raise money...not to reward old bag holders who were conned by Miro years ago. Why split

jondoeuk

jondoeuk 55分前

Calling this the "gold standard" doesn't answer all the underlying concerns. This isn't a refinement of the original external-control analysis either. It uses a completely different set of external comparator trials. That means the reported survival estimate depends on which external patients are se

manibiotech

manibiotech 57分前

Yes we all know that . The previous external control arm patients were “external” , and the one’s in new PSM analysis are also different ‘external’ patients with patient level propensity matching ( so even better controls) and show even better treatment benefit . So again, what is the point you are

Naught

Naught 58分前

Should we expect some notices from. PAC in the very near term then...?

weenphan

weenphan 58分前

I posted on the PCHM board for over a decade. I bought PCHM as low as .0013 and sold stock as high as $5 plus. It was a once in a lifetime percentage gainer. My aliases were LMLYP, Rosesarefree and GeneandDean, which all are references to a band Ween. I'm weenphan on this board.

newflow

newflow 58分前

Ron, Dissolved vs Extinct
No Altaba distributed immediately before dissolution, can you find any company distributing value to equity holders after its complete dissolution long-form or regular Dissolution.
Gemini's Response:
It is important to clarify a key point about Delaware

DA88

Can someone explain who this guy is and why his perspective matters? Love that he is positive, but he doesn’t look like he is anything more than a shareholder.

PickStocks

PickStocks 1時間前

Yes….but we do not have anything to do with Paladin. So it means nothing which is easily verified by a simple phone call….

jondoeuk

jondoeuk 1時間前

Whether this particular analysis has been submitted is something nobody outside NWBO and the MHRA knows.

jondoeuk

jondoeuk 1時間前

This is not simply a refinement of the published JAMA Oncology analysis. It's a different external-control analysis built from a different pool of comparator trials. The fact they constructed a propensity-score matched analysis using individual patient data from AVAGLIO, CENTRIC, and CORE, means the

ihorchu

ihorchu 1時間前

A fantastic day to remember! Since no humidity here, heat is very tolerable.

Allergy Therapeutics (PK)

Titan Machinery

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。